Cyclophilin-A: A novel biomarker for untreated male essential hypertension

Biomarkers

Volumn 18, Issue 8, 2013, Pages 716-720

  Chang, Chen Shu ^a,b   Su, Shih Li ^a,c   Chang, Chia Chu ^a   Lee, Kwo Whei ^a   Kuo, Chen Ling ^a   Huang, Ching Shan ^a   Tseng, Wan Min ^a   Liu, Chin San ^a,d  

^a CHANGHUA CHRISTIAN HOSPITAL   (Taiwan)

^b CENTRAL TAIWAN UNIVERSITY OF SCIENCE AND TECHNOLOGY   (Taiwan)

^c CHUNG SHAN MEDICAL UNIVERSITY   (Taiwan)

^d CHINA MEDICAL UNIVERSITY   (Taiwan)

Author keywords

Atherosclerosis; Cyclophilin A; Cytokine; Hypertension

Indexed keywords

CYCLOPHILIN A; ENDOTHELIAL LEUKOCYTE ADHESION MOLECULE 1; GELATINASE A; GELATINASE B; INTERLEUKIN 2; INTERLEUKIN 4; NITRIC OXIDE; SELENIUM; VASCULAR CELL ADHESION MOLECULE 1;

ADULT; ARTICLE; BODY MASS; CLINICAL ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DIASTOLIC BLOOD PRESSURE; ESSENTIAL HYPERTENSION; HUMAN; HYPERLIPIDEMIA; MALE; PATHOGENESIS; SYSTOLIC BLOOD PRESSURE;

BIOLOGICAL MARKERS; BLOOD PRESSURE; BODY MASS INDEX; CASE-CONTROL STUDIES; CYCLOPHILIN A; CYTOKINES; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; MALE; MIDDLE AGED;

EID: 84889800884     PISSN: 1354750X     EISSN: 13665804     Source Type: Journal    
DOI: 10.3109/1354750X.2013.847122     Document Type: Article

References (34)

1. Arora K, Gwinn WM, Bower MA, et al. (2005). Extracellular cyclophilins contribute to the regulation of inflammatory responses. J Immunol 175:517-22
2. Bermudez EA, Rifai N, Buring J, et al. (2002). Interrelationships among circulating interleukin (IL)-6, C-reactive protein, and traditional cardiovascular risk factors in women. Arterioscler Thromb Vasc Biol 22:1668-73
3. Blann AD, Tse W, Maxwell SJ, Waite MA. (1994). Increased levels of the soluble adhesion molecule E-selectin in essential hypertension. J Hypertens 12:925-8
4. Brown CD, Higgins M, Donato KA, et al. (2000). Body mass index and the prevalence of hypertension and dyslipidemia. Obes Res 8: 605-19
5. Chrysohoou C, Pitsavos C, Panagiotakos DB, et al. (2004). Association between prehypertension status and inflammatory markers related to atherosclerotic disease: The ATTICA study. Am J Hypertens 17: 568-73
6. Davey Smith G, Lawlor DA, Harbord R, et al. (2005). Association of c-reactive protein with blood pressure and hypertension. Arteriosclerosis Thromb Vascular Biol 25:1051-60
7. Friedewald WT, Levy RI, Fredrickson DS. (1972). Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin Chem 8: 499-502
8. Green LC, Wagner DA, Glogowski J, et al. (1982). Analysis of nitrate, nitrite, and [15N] nitrate in biological fluids. Anal Biochem 126: 131-8
9. Handschumacher RE, Harding MW, Rice J, et al. (1984). Cyclophilin: A specific cytosolic binding protein for cyclosporin A. Science 226: 544-7
10. Hwang SJ, Ballantyne CM, Sharrett AR, et al. (1997). Circulating adhesion molecules VCAM-a, ICAM-1, and E-selectin in carotid atherosclerosis and incident coronary heart disease cases. Circulation 96:4219-25
11. Iiyama K, Nagano M, Yo Y, et al. (1996). Impaired endothelial function with essential hypertension assessed by ultrasonography. Am Heart J 132:779-82
12. Jin ZG, Melaragno MG, Liao DF, et al. (2000). Cyclophilin A is a secreted growth factor induced by oxidative stress. Circ Res 87: 789-96
13. Kato N, Sugiyama T, Morita H, et al. (1999). Lack of evidence for association between the eNOS gene and hypertension. Hypertension 33:933-6
14. Komatsu S, Panés J, Russell JM, et al. (1997). Effects of chronic arterial hypertension on constitutive and induced intercellular adhesion molecule-1 expression in vivo. Hypertension 29:683-9
15. Kummayinka SK. (1997). The impact of obesity on hypertension management in African Americans. J Healthcare Poor Underserved 8: 352-64
16. Kuroda YT, Komamura K, Tatsumi R, et al. (2001). Vascular cell adhesion molecule-1 as a biochemical marker of left ventricular mass in the patients with hypertension. Am J Hypertens 14:868-72
17. Lacy F, O'Connor DT, Schmid-Schonbein GW. (1998). Plasma hydrogen peroxide production in hypertensives and normotensive subjects at enetic risk of hypertension. J Hypertension 16:291-303
18. Lim CS, Shalhoub J, Gohel MS, et al. (2010). Matrix metalloproteinases in vascular disease-a potential therapeutic target? Curr Vasc Pharmacol 8:75-85
19. Li-Saw-Hee FL, Edmunds E, Blann AD, et al. (2000). Matrix metalloproteinase-9 and tissue inhibitor metalloproteinase-1 levels in essential hypertension. Relationship to left ventricular mass and anti-hypertensive therapy. Int J Cardiol 75:43-7
20. McGowan MW, Artiss JD, Strandbergh DR, Zak B. (1983). A peroxidase-coupled method for the colorimetric determination of serum triglycerides. Clin Chem 29:538-42
21. Miller MA, Kerry SM, Cook DG, Cappuccio FP. (2004). Cellular adhesion molecules and blood pressure interaction with sex in a multiethnic population. J Hypertens 22:705-11
22. Nigro P, Satoh K, O'Dell MR, et al. (2011). Cyclophilin A is an inflammatory mediator that promotes atherosclerosis in apolipoprotein E-deficient mice. J Exp Med 208:53-66
23. Oparil S, Zaman MA, Calhoun DA. (2003). Pathogenesis of hypertension. AnnIntern Med 139:761-76
24. Olsen MH, Wachtell K, Aalkjaer C, et al. (2002). Vasodilatory capacity and vascular structure in long-standing hypertension: A LIFE substudy. Losartan Intervention For Endpoint-Reduction in Hypertension. Am J Hypertens 15:398-404
25. Onal IK, Altun B, Onal ED, et al. (2009). Serum levels of MMP-9 and TIMP-1 in primary hypertension and effect of antihypertensive treatment. Eur J Intern Med 20:369-72
26. Panek AN, Bader M. (2006). Matrix reloaded: The matrix metalloproteinase paradox. Hypertension 47:640-1
27. Pi-Sunyer FX. (1993). Medical hazards of obesity. Ann Intern Med 119: 655-60
28. Satoh K, Matoba T, Suzuki J, et al. (2008). Cyclophilin A mediates vascular remodeling by promoting inflammation and vascular smooth muscle cell proliferation. Circulation 117: 3088-98
29. Satoh K, Nigro P, Berk BC. (2010). Oxidative stress and vascular smooth muscle cell growth: A mechanistic linkage by cyclophilin A. Antioxid Redox Signal 12:675-82
30. Satoh K, Nigro P, Matoba T, et al. (2009). Cyclophilin A enhances vascular oxidative stress and the development of angiotensin II-induced aortic aneurysms. Nat Med 15:649-56
31. Tuttle RS, Boppana DP. (1990). Antihypertensive effect of interleukin-2. Hypertension 15:89-94
32. Touyz RM. (2000). Oxidative stress and vascular damage in hypertension. Curr Hypertens Rep 2:98-105
33. Warnick GR, Benderson J, Albers JJ. (1982). Dextran sulfate-Mg2+ precipitation procedure for quantitation of high-density-lipoprotein cholesterol. Clin Chem 28:1379-88
34. Yang Y, Lu N, Zhou J, et al. (2008). Cyclophilin A up-regulates MMP-9 expression and adhesion of monocytes/macrophages via CD147 signalling pathway in rheumatoid arthritis. Rheumatology (Oxford) 47:1299-310.